講者：吳東霖
日期：2016-05-10
觀看: 1154
  • 00:00 1.
    Long-term Treatment Outcomes for Patients with Localized Prostate Cancer – Radical Prostatectomy
  • 00:01 2.
    Patient characteristics
  • 01:00 3.
    Biochemical free survival
  • 01:33 4.
    Biochemical recurrence free survival
  • 02:13 5.
    Cancer Specific Survival
  • 02:31 6.
    Cancer Specific Survival
  • 03:08 7.
    Prostate Cancer Specific Survival
  • 03:26 8.
    Radical ProstatectomyKSVGH, n=302
  • 04:30 9.
    Radical prostatectomy
  • 05:00 10.
    Overall Survival
  • 05:19 11.
    Complications of RaLRP Chi-Mei Experience
  • 06:39 12.
    Functional outcome - Radical prostatectomy
  • 07:01 13.
    Functional outcomes of RaLRP Chi-Mei Experience
  • 索引
  • 筆記
  • 全螢幕
【醫藥護人員場】7. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-根除手術
長度: 07:46, 瀏覽: 1155, 最近修訂: 2017-05-09
演講時間：10:30-11:30
講者：吳東霖主任  
現任職位/稱：
高雄榮總外科部主任
國立陽明大學醫學院醫學系兼任副教授
國防醫學院兼任副教授
台灣泌尿科醫學會理事
台灣外科醫學會理事
 
 
    上一篇 下一篇
    • 00:00 1.
      Long-term Treatment Outcomes for Patients with Localized Prostate Cancer – Radical Prostatectomy
    • 00:01 2.
      Patient characteristics
    • 01:00 3.
      Biochemical free survival
    • 01:33 4.
      Biochemical recurrence free survival
    • 02:13 5.
      Cancer Specific Survival
    • 02:31 6.
      Cancer Specific Survival
    • 03:08 7.
      Prostate Cancer Specific Survival
    • 03:26 8.
      Radical ProstatectomyKSVGH, n=302
    • 04:30 9.
      Radical prostatectomy
    • 05:00 10.
      Overall Survival
    • 05:19 11.
      Complications of RaLRP Chi-Mei Experience
    • 06:39 12.
      Functional outcome - Radical prostatectomy
    • 07:01 13.
      Functional outcomes of RaLRP Chi-Mei Experience
    位置
    1. 知識庫
    2. ...
    3. 2016臺大攝護祭-醫藥護人員場
    資料夾名稱
    2016臺大攝護祭-醫藥護人員場
    發表人
    系統管理者
    單位
    泌尿部
    建立
    2016-05-10 12:30:00
    最近修訂
    2017-05-09 09:59:35
    長度
    07:46
    1. 知識庫
    2. ...
    3. 2016臺大攝護祭-醫藥護人員場
    1. 1.
      【醫藥護人員場】活動議程
    2. 2.
      【醫藥護人員場】1. Updates of Prostate Cancer Treatment Guidelines 2015/2016: EAU, NCCN, AUA
    3. 3.
      【醫藥護人員場】2. Prostate Cancer Screening、Observation、and Active Surveillance in Taiwan
    4. 4.
      【醫藥護人員場】3. Novel Therapies for Patients with Metastatic Prostate Cancer
    5. 5.
      【醫藥護人員場】4. Radium-223 (Xofigo, 鐳治骨)
    6. 6.
      【醫藥護人員場】5. Enzalutamide (Xtandi, 安可坦)
    7. 7.
      【醫藥護人員場】6. Denosumab (XGEVA, 癌骨瓦)
    8. 8.
      【醫藥護人員場】7. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-根除手術
    9. 9.
      【醫藥護人員場】8. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-放射治療
    10. 10.
      【醫藥護人員場】9. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-冷凍治療
    11. 11.
      【醫藥護人員場】10. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-HIFU治療
    12. 12.
      【醫藥護人員場】11. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-綜合比較與總結
    13. 13.
      【醫藥護人員場】12. Novel Life-Prolonging Endocrine Therapies for Metastatic Castration-Resistant Prostate Cancer
    14. 14.
      【醫藥護人員場】13. Medical and Surgical Treatment of Male Urinary Incontinence
    15. 15.
      【醫藥護人員場】14. Prevention and Management of Acute Urinary Retention in Men with Prostate Hypertrophy
    16. 16.
      【醫藥護人員場】15. The Art of Treatment for Nocturia
    17. 17.
      【醫藥護人員場】16. Storage Urinary Symptoms: 2016 Updates
    18. 18.
      【醫藥護人員場】17. Surgical Treatments for Prostate Hypertrophy with Urinary Symptoms 2016
    Copyright © 2017 TMUA, All rights reserved.